Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-01 4:02 pm Purchase | 13G | PLURI INC PLUR | Slager David Mark | 2,812,099 6.7% | 506,222 (+21.95%) | View |
| 2023-02-06 3:45 pm Purchase | 13G | PLURI INC PLUR | Slager David Mark | 2,305,877 5.9% | 2,305,877 (New Position) | View |
| 2022-02-01 4:20 pm Purchase | 13G | VASCULAR BIOGENICS LTD VBLT | Slager David Mark | 3,554,082 5.13% | 3,554,082 (New Position) | View |
| 2022-01-26 1:52 pm Purchase | 13G | PLURISTEM THERAPEUTICS, INC. C PSTI | Slager David Mark | 1,685,038 5.25% | 1,685,038 (New Position) | View |
| 2021-02-09 3:52 pm Purchase | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | Slager David Mark | 1,344,123 5.04% | 27,800 (+2.11%) | View |
| 2020-02-11 11:46 am Sale | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | Slager David Mark | 1,316,323 7.4% | -11,293 (-0.85%) | View |